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Abstract
Introduction: Rheumatoid arthritis synovial fibroblasts (RASF) are key players in synovial pathophysiology and are 
therefore examined extensively in various experimental approaches. We evaluated, whether passaging during culture 
and freezing has effects on gene expression and cell proliferation.
Methods: RASF were passaged for up to 8 passages. RNA was isolated after each passage and cDNA arrays were 
performed to evaluate the RNA expression pattern during passaging. In addition, doubling time of the cells was also 
measured.
Results: From passages 2-4, mRNA expression did not change significantly. Gene expression in RASF started to change 
in passages 5-6 with 7-10% differentially expressed genes. After passages 7-8, more than 10% of the genes were 
differentially expressed. The doubling rate was constant for up to 5 passages and decreased after passages 6-8. After 
freezing, gene expression of the second passage is comparable to gene expression prior to freezing.
Conclusions: The results of this study show, that experiments, which examine gene expression of RASF and shall 
reflect or imitate an in vivo situation, should be limited to early culture passages to avoid cell culture effects. It is not 
necessary to stop culturing SF after a few passages, but to keep the problems of cell culture in mind to avoid false 
positive results. Especially, when large-scale screening methods on mRNA level are used. Of note, freezing does not 
affect gene expression substantially.
Introduction
Predominant features of rheumatoid arthritis (RA) are
synovial hyperplasia, synovial cell activation and articular
inflammation associated with subsequent cartilage and
bone destruction [1]. In this scenario, activated synovial
fibroblasts (SF) are key players in joint destruction at the
site of invasion into articular cartilage and bone [1-5].
They maintain their aggressive phenotype towards carti-
lage even when primarily cultured and thereafter co-
implanted together with normal human cartilage into
immunodeficient severe combined immunodeficient
mice (SCID) mice for an extended period of time [5].
To inhibit the progressive growth at the invasion zone
followed by cartilage and bone degradation without inter-
fering with physiologic matrix remodeling, identification
of pathways operative specifically in RASF and not in SF
of other origin (e.g. osteoarthritis SF) is essential. There-
fore, genes showing a dysregulation that is restricted to
RASF are the experimental target of numerous research
groups [6-17].
Various strategies, for example differential display, sub-
tractive cell-hybridization, and cDNA arrays and many
more, have been developed to examine tissue- and dis-
ease-specific differences in gene expression [10,11,18-23].
In addition, a variety of experiments that address the
evaluation of pathways of cartilage and bone destruction
and their underlying mechanisms were performed with in
vitro  cultured RASF populations isolated from tissue
samples obtained during synovial joint replacement.
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Moreover, to test the effects of new drugs or novel treat-
ment strategies, in vitro or in animal models experiments
with cultured RASF are essential [8,10,14,24-26].
In contrast to these goals and these experimental
approaches, even when the RASF appear activated and
'transformed', they are not fast growing or immortal
tumor cell lines, which show a constant geno- and/or
phenotype for an extended cultivation period. They are
slow to moderately proliferating cell populations, which
during cultivation may alter their in vivo phenotype when
devoid of their normal environment. In addition, in con-
trast to fast-proliferating tumor cells, in RA only limited
amounts of synovial cells, and therefore limited amounts
of mRNA, can be obtained for molecular analysis. There-
fore, the cells are often grown over several passages to
obtain sufficient cellular material to perform the required
experiments. In this situation, it is frequently difficult to
know whether the cell population after an extended culti-
vation time is still identical to the RASF population
shortly after isolation from the tissue. Moreover, passag-
ing may result in a selection pressure for parts of the cell
population, for example adherent cells vs. trypsin-sensi-
tive cells, that are being removed to a different extent
from the culture flask during passaging and that may alter
the overall gene expression profile in higher passages and
lead to different results when compared with earlier pas-
sages.
To evaluate whether cell culture effects take place in
RASF cultures over several passages, we performed
cDNA array analysis for up to nine passages. Early pas-
sages were compared with later passages to evaluate
alteration of gene expression as consequence of cell cul-
ture in detail. In addition, the proliferation rate was mea-
sured by the doubling time of the population over the
passaging time of the cells to evaluate changes in cell
growth rates in comparison to earlier passages.
Materials and methods
Synovial tissue and cell culture
Synovial tissues were obtained from synovial biopsies of
six patients with RA undergoing joint surgery (synovec-
tomy or joint replacement by prosthesis implantation),
who all met the criteria of the American College of Rheu-
matology [27]. The tissue samples were obtained during
routine surgery at the Department of Orthopedics of the
University of Regensburg, where approved by the local
ethics committee and patients involved gave informed
consent. Culture of SF was performed as described
recently [5]. Following enzymatic digestion, fibroblasts
were grown in DMEM (Biochrom, Berlin, Germany) con-
taining 10% heat inactivated FCS (Gibco Life Technolo-
gies, Grand Island, NY, USA), 100 U/ml penicillin and
streptomycin (PAA Laboratories GmbH, Linz, Austria)
and cultured for four passages at 37°C in 10% carbon
dioxide. The SF were stained for a fibroblast marker by
immunohistochemistry. More than 95% could be stained
positively for the fibroblast enzyme prolyl 4-hydroxylase
and none were positive for the macrophage marker CD68
or the neutrophil marker cathepsin G after the second
passage of cultivation with enzymatic digestion equalling
passage 0 (data not shown). Routine tests for mycoplasms
were negative. At 85 to 95% confluency, cells were pas-
saged 1:2 and a part of the cells was harvested. Total RNA
was extracted and stored at -70°C. Culture conditions
were (and have to be) kept constant during the experi-
ments. Passaging of the cells was performed at 85 to 95%
confluency as fibroblasts exhibit contact inhibition
(unpublished observations) and were passaged 1:2 to pro-
vide cell-cell contacts between the cells.
Cell culture proliferation measurement
After enzymatic digestion of the tissue (passage 0), the
cells were grown to 85 to 95% confluence, then
trypsinized, counted and 50,000 cells were seeded into
five fresh cell culture six-wells (passage 1). Each day, one
well was trypsinized and the cells were counted. The day
at which the double cell number (>100,000) occurred was
noted. At 85 to 95% confluency, this procedure was
repeated (passage 3) until passage 8. The doubling time in
days was determined as 'doubling point', when the cells
doubled their number (100,000) as compared with the
day they were counted (50,000) and seeded.
Storage of cells in liquid nitrogen
For evaluation of the effects of freezing, that is storage in
liquid nitrogen, cells in passage 1 (the passage after enzy-
matic digestion) were trypsinized, centrifuged and resus-
pended in FCS with 10% DMSO (dimethyl sulfoxide) (v/
v) in a 1 ml cryovial. Cells were immediately stored on ice,
placed in a freezer and frozen over night at -80°C (freez-
ing speed about 1°C/min). Thereafter, cells were directly
transferred to liquid nitrogen.
To thaw the cells, the cryovials were carefully thawed at
37°C, the cell suspension transferred into preheated
(37°C) culture medium and centrifuged to remove the
DMSO. It was resuspended in culture medium and then
transferred into cell culture flasks and cultured (passage 2
for the cells after cryostorage) and passaged for up to six
passages under standard conditions as outlined above.
RNA extraction
Total cellular RNA was extracted from human fibroblasts
using the RNeasy spin column purification kit (Qiagen,
Hilden, Germany). To remove contaminating genomic
DNA, total RNA was treated with DNase I (0.2 U/μl;
Boehringer Mannheim, Mannheim, Germany) for 40
minutes at 37°C. RNA concentrations were measured
using the Ribogreen RNA quantification kit (Molecular
Probes, Leiden, the Netherlands), adjusted to 200 ng/μl inNeumann et al. Arthritis Research & Therapy 2010, 12:R83
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water and stored at -70°C. Equal aliquots were then elec-
trophoresed on 1% agarose gels stained with ethidium
bromide to compare large and small rRNAs qualitatively
and to exclude degradation. When starting with fresh
RNAs, one RNA arbitrarily primed(RAP)-PCR was per-
formed (details see below) without the reverse tran-
scriptase as a control for DNA contamination.
RNA arbitrarily primed PCR of total cellular RNA
RAP-PCR of total cellular RNA was performed as
described previously [6,11,22]. As a template for each
experiment, 250 ng of RNA was used. First-strand syn-
thesis was carried out using MuLV (Moloney murine leu-
kemia virus) reverse transcriptase (Promega, Madison,
WI, USA) and 2 μM first strand arbitary primer. Second
strand synthesis was performed in a 20 μl reaction using
AmpliTaq Stoffel Fragment (Perkin Elmer, Norwalk, CT,
USA), 2.8 μl [α-32P]dATP (3,000 Ci/mmol, 10 mCi/ml),
and 4 μM arbitrary second primer. Subsequently, the
reaction was cycled through 30 low stringency cycles (30
seconds 94°C, 30 seconds 35°C, 30 seconds 72°C). Primer
combination for RAP-PCR was: OPN23 (5'-CAG GGG
CAC C-3') for first strand and OPN21 (5'-ACC AGG
GGC A-3') for second strand synthesis.
Atlas™ cDNA expression array
Two different AtlasTM human cDNA expression array
membranes (Clontech, Palo Alto, CA, USA) containing
the human cDNAs were used: The Atlas Human Cancer
cDNA Expression Array and the Atlas Human Oncogene
cDNA Expression Array. From each of these genes,
cDNA was amplified using RAP-PCR as described
recently [10,11].
Preparation of cDNA probes
T h e  PCR  p r od u c ts  w e r e  p u r i f i e d  f r o m  u n i n c o rpo r a t ed
32P-labeled nucleotides and small cDNA fragments (<0.1
kb) by column chromatography using NucleoSpin®
Extraction Kit (Clontech, Palo Alto, CA, USA) as outlined
by the producer. A total volume of 100 μl was used for
hybridization. A 2 μl sample of the purified probe was
measured by scintillation counting.
Hybridization
The cDNA was hybridized to the Atlas™ human cDNA
expression array membranes in roller bottles. The filters
were transferred to roller bottles and prehybridized in 5
ml prewarmed (68°C) hybridization solution
(ExpressHyb Hybridization Solution, Clontech, Palo Alto,
CA, USA) with 100 μg/ml fragmented denatured salmon
sperm DNA in a hybridization oven. The labeled cDNA
probe was diluted 1:10 with 10 times denaturing solution
(1M NaOH, 10 mM EDTA) and incubated at 68°C for 20
m i n u t e s .  A  5  μ l  ( 1  μ g / μ l )  s a m p l e  o f  s h e a r e d  h u m a n
genomic DNA was added with an equal volume of two
times neutralizing solution (1 M NaH2PO4, pH 7.0) and
incubated for 10 minutes at 68°C. The mixture was added
to the filters with the hybridization solution and hybrid-
ized over night.
Wash
The filters were washed three times in wash solution 1 (2
× SSC (saline sodium citrate) and 2% SDS) for 30 minutes
at 68°C each. Two washing steps were performed with
wash solution 2 (0.1 × SSC and 0.5% SDS) at 68°C for 20
minutes and one step for five minutes at room tempera-
ture in 2 × SSC and then exposed to a Phosphor-Imager-
Screen (Molecular Dynamics, Sunnyvale, CA, USA) for
three to five days depending on the intensity of radiation
of the bound fragments. Data analysis was performed
using the Ambis software (ImageQuant, Molecular
Dynamics, Sunnyvale, CA, USA). Evaluation was per-
formed using the AtlasImage™ 2.7 software, developed
specifically for analysis of the Atlas™ cDNA Expression
Arrays (Clontech, Palo Alto, CA, USA [28]). Data com-
parison data have been deposited in the NCBI GEO data-
b a s e  w i t h  t h e  s e r i e s  r e c o r d  a c c e s s  n u m b e r
[GEO:GSE21385].
Array comparison and statistical evaluation
To compare arrays of different hybridizations using the
Atlas™ array system, background and signal intensity
need to be normalized. The default signal threshold
determined by the software was used and kept constant
for all analyses. After background correction of the
arrays, the median signals for all spots on an array were
used to calculate the correction coefficient (global nor-
malization), which demonstrated to be the most reliable
method for the AtlasImage 2.7 software for our array set-
tings [28].
Statistical evaluation for multiple array comparison was
performed using Lavene-test followed by t-test (paramet-
ric) or by Mann-Whitney U test (non-parametric), with
significance level correction according to the number of
compared genes (Bonferroni adjustment) as described
previously [28]. For 100 comparisons, a random signifi-
cance of P < 0.05 in 5 of 100 comparisons occurs (α-Fac-
tor). Therefore, the significance level was adjusted: P =
0.05/ncomparisons (e.g for 100 comparisons the new signifi-
cance level is P < 0.0005). Only genes that reached the
statistical significance level after Bonferroni-correction
were regarded as being differentially expressed.
Real-time PCR
Real-time PCR was performed using a LightCycler sys-
tem (Roche Diagnostics, Mannheim, Germany). Reac-
tions were performed in a 20 μl volume with 0.5 μM
primers; CD82 for 5'-TAT GTC TTC ATC GGC GTG
GG-3'; CD82 rev 5'-CAT GAG CTC AGC GTT GTC TG-
3'; c-myc for 5'-CTA TGA CCT CGA CTA CGA CT-3'; c-Neumann et al. Arthritis Research & Therapy 2010, 12:R83
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myc rev 5'-CGC AGA TGA AAC TCT GGT TC; 18S-for
5'-TCA AGA ACG AAA GTC GGA G-3'; 18S-rev: 5'-
GGA CAT CTA AGG GCA TCA CA-3'), 3 mM MgCl2
concentration, and 2 μl LightCycler-FastStart Reaction
Mix SYBR Green I (Roche Diagnostics, Mannheim, Ger-
many). After 10 minutes polymerase activation at 95°C,
40 cycles with 95°C for 15 seconds, 52°C for 5 seconds
and 72°C for 20 seconds were performed. Fluorescence
was measured at the end of the 72°C extension period.
Efficiencies of the primers were tested using the standard
curve method (E = 10-1/slope). According to the guidelines
of the manufacturer, efficiencies of 2.00 ± 0.05 were con-
sidered acceptable for experiments. To confirm amplifi-
cation specificity, the PCR products were subjected to a
melting curve analysis to exclude primer dimers and non-
specific amplification. Data were analyzed using the
LightCycler analysis software (Roche, Mannheim, Ger-
many). The baseline of each reaction was equalized by
calculating the mean value of the five lowest measured
data points for each sample and subtracting these values
from each reading point. Background fluorescence was
removed by setting a noise band. In this setting, the num-
ber of cycles at which the best-fit line through the log-lin-
ear portion of each amplification curve intersects the
noise band is inversely proportional to the log of copy
numbers.. The crossing points (CP) are the intersections
between the best fit lines of the log-linear region and the
noise band. The CP determined for the respective genes
were normalized to those of 18S RNA to compensate for
variabilities in the amount of RNA and for exclusion of
general transcriptional effects.
Results
Expression of genes in RASF during cell culture passaging
For each RA patient, the isolated SF cell population was
passaged in two independent experiments. RNA was
extracted and cDNA array experiments were performed.
T h e  c D N A  a r r a y s  w e r e  s u b s e q u e n t l y  h y b r i d i z e d  w i t h
radioactive labeled cDNA probes from the different pas-
sages of the RA patients (Figure 1). Expression patterns of
RASF in early passages in comparison to higher passages
was performed for each patient individually (n = 4) and
the alteration in percentage was calculated and compared
for the four patients (Figure 2). Only genes, that reached
the signal threshold, were constant in the repeated exper-
iments, and reached the statistical significance level after
Bonferroni-correction as described were regarded as dif-
ferentially expressed.
The gene expression patterns of the RASF populations
were constant in all patients during passages 1 to 4 (about
7% difference in gene expression; Figure 2), and one
patient showed even a constant gene expression for up to
five passages (data not shown).
Figure 1 Expression patterns of genes in RASF during the differ-
ent cell culture passages. Example for cDNA arrays of the rheumatoid 
arthritis synovial fibroblasts (RASF) in different passages from one RA 
patient. Sections of the Atlas Human Cancer cDNA Expression Arrays 
are shown. (a) Passage 2, (b) passage 4 with mostly constant expres-
sion when compared with passage 2, (c) passage 5 with changes 
about 7% of the expressed genes when compared with passage 2, and 
(d) passage 8 with changes about 10% of the expressed genes when 
compared with passage 2. p, passage.Neumann et al. Arthritis Research & Therapy 2010, 12:R83
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Of note, passage 0, which is the first culture of adherent
cells after enzymatic digestion (after removing of the
non-adherent cells and the supernatant and after several
washing steps) differed in the expression pattern to each
of the passages 1 to 9 (>10%), indicating that contaminat-
ing cells such as macrophages and endothelial cells are, as
expected from immunocytochemistry, present at passage
0 (data not shown). In detail, the variation of two parallel
cultures of the same RASF populations showed a differ-
ential gene expression of below 1% of the expressed
genes.
Substantial changes of gene expression in the RASF
populations could be detected after passages 5 to 6. They
varied individually for the different patients resulting in
alteration of about 7 to 10% of the analyzed genes (Figure
2a). After passages 7 to 8, more than 10% of the analyzed
genes could be found to be differentially expressed (Fig-
ure 2a). The increase in expression changes, altered dur-
ing passaging, are constant through the passages (Figure
2b). When comparing higher passages with passage 2
instead of passage 1, the same increase of expression
changes in percentage could be detected (regressionline
in Figures 2a and 2b).
Interestingly, the genes that were differentially
expressed at later passages were not identical in the dif-
ferent passages, thus underlining the observation that the
gene expression pattern starts to be inconstant and
diverging in later passages (data not shown). To visualize
the changes between the passages, intensities of the
arrays compared (after background correction) are pre-
sented for one exemplary passage comparison (Figure 3).
In addition to the comparisons between early passages
(passage 1) and higher passages, the graphs for compari-
sons between higher passages are also presented. Of note,
Figure 2 Changes in gene expression during passaging. (a) The changes in gene expression increase substantially during passaging of the cells 
in all fibroblast cultures. In addition, the variations and differences between expression pattern in the different rheumatoid arthritis synovial fibroblasts 
(RASF) cultures increase also in later passages (% changes of gene expression ± standard error of the mean). The regression line shows a clear incre-
ment in the course of the culture of the cells (red). (b) Changes in gene expression comparing higher passages instead of passage 1. (c) Verification 
of CD82 and c-myc regulation using real-time PCR. Passaging was performed in two parallel cultures for each fibroblast population. Real-time PCR was 
performed threefold (six measurements for each population, respectively).Neumann et al. Arthritis Research & Therapy 2010, 12:R83
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the differences between the higher passages (e.g. passage
6 to 7) show a more constant pattern then when com-
pared with very early passages (e.g. passage 1 to 7).
Altered genes included, for example, oncogenes, cytok-
ines, and proliferation-associated genes, but no specific
gene groups were differentially expressed in all patients
and all experiments. Examples of the regulated genes and
gene groups are listed in Table 1. The list of regulated
genes is available at the Arthritis Research and Therapy
homepage. Here, the genes are presented, in which the
differential expression starting in a defined passage
reaches statistical significance and differential expression
continues through passaging of the cell population
(>'passage'). In addition, two genes were verified using
real-time PCR (c-myc oncogene, CD82), indicated with **
for the RA SF populations tested in Figure 2c. Only genes
that reached the signal threshold, were constant in the
repeated experiments, and reached the statistical signifi-
cance level after Bonferroni-correction as described were
stated as differentially expressed. Some of the presented
genes are highlighted in Figure 3, to illustrate the con-
stancy between the passages in one exemplary fibroblast
population. The data reflect, in part, the slowed cell
cycling and reduced proliferation, as most of the regu-
lated genes could be related to this process. But also other
genes, such as cytokine receptors and regulators of other
cellular pathways are altered during passaging (Table 1).
Expression of genes in RASF after storage in liquid nitrogen
T h e  c D N A  a r r a y s  w e r e  s u b s e q u e n t l y  h y b r i d i z e d  w i t h
radioactive labeled cDNA probes from freshly cultured
RASF for up to six passages after thawing of the cells.
Expression patterns of the thawed then cultured RASF
were compared with the freshly cultured cells (with pas-
sage 1 as baseline for constant gene expression basis) as
shown in Figure 4. The changes in the gene expression
pattern after thawing were similar to the not frozen cells
(Figure 2a), and the first passage after thawing (passage 2)
Table 1: Genes, that are differentially expressed during cell culture
Gene group Regulated genes RA-1 RA-2 RA-3 RA-4
Cytokines/-receptors TNF receptor 1 3 ↓ 5-8 ↑ 5  ↑ 3-8 ↑
MCSF I receptor precursor 6,8 ↑ 6-8 ↓ 2 ↓ 5-8 ↓
epidermal growth factor receptor 1 3,4 ↑ -6 - 8 ↑ 4-8 ↑
insulin-like growth factor I receptor >5 ↑ 3,7 ↑ 7-8 ↑ 5,6,8 ↑
Adhesion ILK >5 ↓ 2 ↑ 2,6 ↑ 4-8 ↓
Apoptosis Fas-activated serine/threonine kinase
cytotoxic TRAIL receptor 2 (DR 5)
4-8 ↑ 7-8 ↑ 6 ↑ 6-8 ↑
5-8 ↑ 2¯ 7 - 8 ↓ 8 ↑
Proliferation tumor suppressor LUCA1 6-8 ↑ 7-8 ↑ 7-8 ↑ 6,8 ↑
p33ING1 4-8 ↑ 6-8 ↑ 3-8 ↑ 3-8 ↑
p53 cellular tumor antigen 4-8 ↑ 6,8 ↑ 3,7 ↑ 7-8 ↑
cyclin-dependent kinase inhibitor 1C 6-8 ↑ 2 ↑ 4-8 ↑ -
ski oncogene 7-8 ↑ 4 ↑ 6,7 ↑ 6,8 ↑
Proliferation/Signaling shb proto-oncogene 4-8 ↓ 7-8 ↓ -2 ↓
Signaling notch2 5-8 ↑ 6 ↑ 5,6,8 ￿ ↓ 5 ↓
jun-B 7-8 ↑ 4,5,7,8  ↑ 5-8 ↑ 4,7 ↑
frizzled 7-8 ↑ 8 ↑ 2 ↑ 8 ↑
FRA2 3-8 ↓ 7-8 ↓ 5-7 ↓ 2 ↑
NOTCH1 precursor 5-8 ↑ 5 ↑ 4,5 ↑ 7-8 ↑
Others semaphorin 1 7-8 ↑ -4 - 8 ↓ 3,4 ↑
glycogen synthase kinase 3 alpha 6-8 ↑ 6 ↑ 5-8 ↑ 3-8 ↑
thymosin beta-10 5,6,8 ↓ 4,6,7 ↓ 7-8 ↑ 5-8 ↑
ezrin; cytovillin 2; VIL2 7-8 ↓ 4-8 ↓ 4 ↑ 5 ↓
Exemplary gene groups and genes and their regulations are shown. Only genes, that reached the signal threshold and the statistical significance 
level after Bonferroni-correction as described in methods were regarded as differentially expressed (P < 0.00025).
FRA2: fos-rrelated antigen 2; ILK: integrin-linked kinase; MCSF: macrophage colony-stimulating factor; RA: rheumatoid arthritis; TRAIL: tumor 
necrosis factor related apoptosis inducing ligand; VIL2: villin 2.Neumann et al. Arthritis Research & Therapy 2010, 12:R83
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Figure 3 Changes in gene expression. Results are presented for one rheumatoid arthritis (RA) patient using an Atlas Human Cancer cDNA Expres-
sion Array for direct comparison of the relative intensities of the compared passages, showing strong variations at higher passages in this example. (a 
to g) Passage 1 was compared with higher passages. Examples of two genes are presented. In red: Expression of c-myc. In blue: expression of p33ING1 
during culture of the exemplary RA synovial fibroblasts (SF) population. (h to l) In addition, higher passages are compared with each other showing 
the differential expression pattern between higher passages.Neumann et al. Arthritis Research & Therapy 2010, 12:R83
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showed more changes in gene expression when compared
with passage 3 (Figure 4). Substantial changes of gene
expression in the RASF populations could be detected in
passages 5 to 6 with alterations from 9.5 to 12.0% of the
expressed genes (Figure 4).
Proliferation of RASF during cell culture passaging
The cell doubling rate was measured during passages 1 to
8 as described above by counting the cells each day (par-
allel experiments with equal cell numbers per well as
described in methods). The day after the passaging of the
cells in which the cell number doubled after passaging
was noted for each passage. Interestingly, a constant dou-
bling rate was found in the early passages 3 to 4 and in
most patients in passage 5 (4 ± 1 day), which increased
during the further cultivation of the cells (passages 6 to
8). At later passages the doubling rate was increased up to
seven days, indicating that the 'older' cell populations
show a decreased proliferation rate (Table 2 and Figure
5).
Discussion
T-cell independent pathways, such as upregulation of
proto-oncogenes, production of growth factors and the
release of matrix-degrading enzymes lead to progressive
destruction of the affected joints [2,15]. Transformed-
appearing, activated SF are key players in this synovial
activation [1,2,5]. To identify the underlying mechanisms
of the destructive behavior of RASF, in vitro cultured
RASF are used in various experimental settings
[10,11,13-15]. The analysis of the pathways that may help
to understand the progressive growth at the invasion
zone and the active cartilage and bone degradation with-
out interfering with physiologic matrix remodeling is
therefore mandatory to identify novel therapeutic targets
to inhibit the progressive joint destruction by RASF.
Several cytogenetic and molecular biology techniques
are currently used to identify differentially expressed
genes under different biological conditions, for example
differential display, subtractive hybridization, and cDNA
arrays [9,11,13,19,29]. They are currently used to analyze
molecular changes and mechanisms involved in the
pathogenesis of RA [9-11,30-32]. The advantages of the
current techniques include analysis of gene subsets, com-
parison of more than two biological conditions in combi-
nation with a high sensitivity. In additon, to control the
effects of potential new drug targets such as proliferation
inhibitors, antiinflammatory and destruction inhibiting
molecules, in vitro analysis using RASF or animal models
including the use of human RASF such as the SCID
mouse model for RA are helpful tools
[9,10,18,25,26,32,33]. Unfortunately, high amounts of cel-
lular material (mRNA or protein) are required in most
cases for the different gene or gene product analysis.
To evaluate the critical effects of this passaging proce-
dure in cell culture on gene expression, RASF were there-
fore cultured over several passages followed by cDNA
array analysis for up to eight passages and comparison of
early passages to higher culture passages was performed.
In addition, the effects of the storage of RASF in liquid
nitrogen on gene expression were examined.
As shown in Figure 2, the gene expression pattern of
the RASF populations were constant at passages 2 to 4.
Passage 0 was different when compared with passages 1
to 8 (>10%), which is most likely due to the presence of
macrophages on the culture plate (detectable by immu-
nohistochemistry [1,5]), which are not present at the later
passages 1 to 8. In addition, changes in gene expression of
RASF populations could be detected after passages 5 to 6,
showing changes of 7 to 10% of the analyzed genes (Fig-
ure 2). After passages 7 to 8, more than 10% of the ana-
lyzed genes were differentially expressed combined with
an increasingly inconstant expression pattern at higher
passages.
Thawing of the cells after storage in liquid nitrogen
affected mainly the gene expression of the first passage of
the cells, possibly due to the stress of thawing and the
remaining DMSO until the DMSO was completely
removed. Thereafter, the cells showed a similar pattern of
gene expression when compared with the freshly cultured
RASF as the non-frozen cells (Figures 2 and 3). Moreover,
the proliferation rates of the fibroblast cultures decreased
in later passages, showing a decreased doubling rate after
five to eight passages (Table 2).
Taken together, the data of the study show that experi-
ments, which involve analysis of gene expression and the
Figure 4 Changes in gene expression after storage in liquid nitro-
gen. The changes in gene expression after thawing the cells and cul-
turing for up to six passages were compared with the freshly cultured 
cells with passage 1 as baseline for the comparison. The blue regres-
sion line shows the values for passage 2 to 6 after thawing of the cells 
when compared with passage 1 of the freshly cultured cells, including 
passage 2 (blue square). The red regression line shows the values for 
the passages 3 to 6 without the first passage after thawing of the cells 
(excluding the value in the blue square), showing that the passage im-
mediately after thawing showes higher values of differentially ex-
pressed genes due to the thawing procedure. p, passage.Neumann et al. Arthritis Research & Therapy 2010, 12:R83
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phenotype of RASF, should be limited to early cell culture
passages, that is passages 2 to 5, to avoid cell culture
effects, diverging gene expression at higher passages, and
decreased proliferation of the analyzed RASF popula-
tions. In case of a need for larger cell numbers, for exam-
ple for transduction or animal experiments, an internal
long-term cultivation control should be performed,
which also includes the comparison of early passaged
cells to later passaged cells. In addition, storage of cells in
liquid nitrogen affect mainly gene expression of the first
culture passage after thawing of the cells and therefore,
the second passage should be used for experiments.
Therefore, this paper addresses researchers who per-
form experimental approaches with cultured SF on the
RNA expression level. We want to highlight that cultur-
ing of the cells for a too high number of passages will pro-
duce differences in gene expression in comparison to the
cells used at low passages. Many researchers address the
ability to proliferate, the induction of apoptosis and the
cytokine expression by these experiments. The intention
of the paper is not to recommend excluding culturing
RASF after four or five passages, but to keep the prob-
lems of culturing in mind to avoid false-positive results
and additional, rather labor-consuming, work when veri-
fication of the obtained expression data with fresh cell
cultures is performed. Culture conditions should be kept
constant during the experiments. In addition, we want to
emphasize, that the functional ability of the cells or the
regulation on protein level are not necessarily changed.
Conclusions
The increased potential of high-resolution molecular
analysis techniques for evaluation of cultured synovial
cells, not only reveals the effects of culture on gene
expression, it also illustrates the mandatory duty to take
these effects into account when simulating the in vivo sit-
uation with an in vitro setting.
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Table 2: Cell doubling rates (in days) during cell culture passages for each patient
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± SD 0.43 0.43 0.50 0.71 0.43 0.83 0.50 0.50
The cell doubling rate was measured by counting the cells. The day, the cell numbers were doubled after passaging of the cells is listed for 
each passage.
p: passage; RA: rheumatoid arthritis; SD: standard deviation.
Figure 5 Cell doubling rates (in days) during cell culture passages 
for each patient. The cell doubling rate was measured by counting 
the cells. The day, the cell numbers were doubled after passaging of 
the cells was noted for each passage. The tendency shows a constant 
doubling rate in early passages, which increases during the cultivation 
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